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Healthcare and Substance Use Service Accessibility and Barriers for Syringe Service Program 
(SSP) Participants in Manchester, NH 
Background 
Opioid use is a prevalent topic in New Hampshire, as our state has one of the highest 
rates of death from opioid overdose in the country (CDC, 2018). The current literature 
surrounding people who inject drugs’ (PWID) experiences and needs indicate a lack of access to 
preventative care and treatment resources. However, many of these inquiries are not specific to 
New Hampshire’s PWID (Artenie, 2015; Al-Tayyib, 2015) but instead focus on the population as 
a whole. Decreased resources are even more prevalent due to COVID (Nolte et al., 2020). One of 
the goals of Syringe Services Programs (SSPs) is to engage participants in connecting with 
services and offering low barrier access to resources. SSPs offer sterile supplies, education, and 
support to PWID (CDC, 2016). SSPs demonstrate reductions in overdose deaths, communicable 
disease transmission (HIV and Hepatitis C), and infection rates such as endocarditis and 
abscesses (CDC, 2017). Fifty percent of participants who engage with an SSP reduce their use 
after engagement and are five times more likely to enter a substance use treatment program 
(CDC, 2017). SSPs also know how to engage PWID with compassion, as these persons face 
discrimination in the community (Kidorf, 2011). Although the benefits of SSPs are clear there is 
little knowledge about factors that enable or constrain SSP participants’ healthcare engagement.  
PWID often face discrimination in the inpatient setting due to their drug use and blood-
borne diseases (Maffina et al., 2013). Effective engagement of PWID is even more critical given 
the greater physiological vulnerability to infectious disease including HIV and Hepatitis C 
(HCV). PWID are more likely to leave against medical advice (AMA) which often leads them to 
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not completing recommended treatment and therefore at higher risk for health issues to progress 
to a chronic or more life-threatening stage (Biancarelli et al., 2019).   
Experiencing discrimination within healthcare can negatively impact engagement in care 
and receipt of effective treatment. When PWID feel as though they are being discriminated 
against they are less likely to honestly disclose information about their health and their drug use 
and are less likely to stay engaged in harm reduction services (Henwood et al., 2014). Some fear 
the loss of control over their prescribed opioid to the point of wanting to avoid the healthcare 
realm altogether, obtaining heroin and opioids from the street to achieve relief instead (Marie, 
2014). Although multiple sources describe the difficulties, few effective interventions have been 
identified to integrate into the inpatient setting to address these concerns.  
Community-based resources are often the healthcare setting of choice for PWID. 
Supervised injection facilities, rarely available within the US, provide non-judgmental treatment 
and a safer environment for PWID not only physically, but socially and emotionally.  These 
facilities provide integrated care with access to counseling and social services, which is not 
typically found in the inpatient setting (Lang, et al., 2013). Use of harm reduction approaches, 
like supervised injection facilities, demonstrates to PWID that providers value, care for, respect, 
and dignify patients as individuals.  Harm reduction strategies result in providers celebrating any 
positive change toward better health and used positive reinforcement as a building block in the 
patient-provider relationship (Rosenburg & Davis, 2013).  In a harm reduction approach, 
providers recognize that PWID require support during any transition toward risk reduction. 
Evidence for harm reduction approaches has been primarily built up in community-based 
settings. Thus, connecting PWID to community programs increases the chance in continuity of 
care for these patients secondary to the support received in such settings.    
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 The current literature outlines multiple factors that lead to negative interaction for 
PWID in healthcare. Firstly, PWID often feel that their pain is not well managed, which is 
associated with feelings of isolation, shame, humiliation, and poor communication with the 
healthcare team (Marie, 2014). Other PWID on chronic opioid therapy also reported fear of 
losing control of their prescribed opioid, wanting to hide treatment from others, and feeling 
stigmatized when receiving treatment for pain.  (Marie, 2014).  
Negative experiences for PWID with healthcare and are missed opportunities to support 
positive change. PWIDs report some service providers are unable to provide effective services 
due to a lack of resources and education (Maffina et al., 2009). In most cases, there is mutual 
mistrust between the provider and the patient, which creates a barrier for treatment and 
communication. PWID have cited poor interaction with service providers as the main reason for 
avoiding care (Maffina et al., 2013). PWID describe being denied access or resources as 
stigmatizing and embarrassing, leading to internalization and reaction to stigma (Paquette et al., 
2018). PWID associated this stigmatization with delayed and substandard care of overdoses and 
injection-related infections (Paquette et al., 2018).  
Positive interactions between healthcare professionals and patients are essential in 
engaging PWID in high quality care. When PWID feel welcomed in the hospital they are more 
inclined to connect to resources. Establishing rapport is important for healthcare professionals 
when communicating with all patients, but especially important with PWID due to the 
disproportion of health disparities they face. Patient outcomes are optimized when care is 
delivered in a non-judgmental and respectful manner (Paquette et al., 2018).  
Although the majority of interactions PWID face within healthcare literature have been 
described as negative, this highlights the great potential to address and promote positive 
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interactions. Key factors in positive interactions include transparent and continuous honest 
communication between patients and their health caregivers (Marie, 2014). PWID value 
relationships with family, extended family, and their supports who they perceive view their 
circumstances optimistically (Small et al., 2009). Despite these findings, providers may be less 
likely to engage family and friends of PWID than other clients. Providers could benefit from 
recognizing the power they have and therefore remain and ally and advocate for their clients. 
Once a provider-client relationship is established it is maintained. A key component of 
maintaining a positive provider-client relationship is by understanding that abstinence-only goals 
during recovery are not realistic for every PWID (Small et al., 2009). A critical time to show 
support for a PWID are during those times in which they may still be moderately using. Support 
being withheld during this transition time between moderate use and abstinence, could actually 
put the patient at risk for isolation from resources and support (Hawk et al., 2017). Instead, Hawk 
and colleagues (2017) recommend positive reinforcement to be rewarded as an encouraging 
incentive to continue to strive towards sobriety. 
Community-based resources are preferred by PWID as a safe and welcoming place to 
receive care and connection to counseling and other social services (Lang et al., 2013). Needle 
exchange programs are becoming more prevalent here in NH as well as across the country and 
have been shown to incentivize clients to seek primary care (Lang et al., 2013). Although 
equitable care is often perceived more by patients in the outpatient setting, these strategies have 
also seen positive results when integrated into the inpatient setting. For instance, PWID found 
lower levels of using when they were offered multidisciplinary support services for substance 
misuse in the inpatient setting (Wakeman et al., 2017). 
 
HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS 6 
 
 
The primary aim of the study was to identify the health service needs of SSP participants 
in Manchester, NH. To answer this question more accurately, it was  broken into five sub-
questions: 
1. What healthcare services are SSP participants accessing and what is their 
satisfaction with those services? 
2. What substance use services are SSP participants accessing and what is their 
satisfaction with those services? 
3. What barriers to accessing medical care do SSP participants face? 
4. How did COVID affect this access to substance use services and healthcare 
services? 
5. Is there an association between accessing substance use (SU) and healthcare 
services with length of engagement with an SSP? 
 
 
Methods and Materials 
This study was conducted between November 2020 and May 2021. The study was 
University of New Hampshire IRB approved (#8386) and funded by the UNH Collaborative 
Research Excellence (CoRE) program. A Qualtrics survey was administered to up to two 
hundred participants of fours SSP in New Hampshire. Data collection is still ongoing at one site. 
This study focuses on Manchester subset of data that engaged Queen City Exchange participants. 
These surveys were completed in November and December 2020. Criteria for inclusion was 
being at least 18 years of age and actively participating in an SSP. The Qualtrics survey took 
approximately 15 to 20 minutes and was administered on a tablet. The survey included audio-
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computer assisted self-interview (ACASI), as this is best practice to accommodate those who 
would prefer questions read for them, including low literacy individuals. The survey explored 
items including syringe access, use of safe supplies, healthcare services, substance use, substance 
use services, infection prevention, overdose/naloxone, and demographics. A $20 gift card was 
provided for participation in the study. From January to April of 2021, data analysis was 
conducted on SPSS Statistics. Additional analysis and graphing were completed on Excel. A chi 
square test was utilized to test associations between SSP engagement and accessing services.  
Results 
Recruitment for this study yielded 81 participants (demographics listed in Table 1). The 
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The survey questioned participants regarding the healthcare services accessed (Table 2). 
The most utilized non-emergent service was primary care (n=46, 56.7%), while the most 
accessed emergent services with the emergency department (n=55, 67.9%).  
Table 2 
Healthcare Services Accessed (N=81) % n 
Accessed ANY Services 91.3% 74 
Accessed ANY Non-Emergency Care 71.6% 58 
Primary care 56.7 46 
Mental health services (counselling, psychiatry) 46.9 38 
Health department (Manchester or Nashua) 24.6 20 
Health clinic or van (ie Healthcare for the Homeless) 24.6 20 
Accessed ANY Emergency Care 75.3% 61 
Emergency Department 67.9 55 
Walk in/ Urgent care 42.0 34 
 
The survey questioned participants if they felt satisfied with the support received by these 
services (Figure 1). Overall, participants were the most satisfied with the support received from 
primary care (n=36, 78.2%), and the least satisfied with health clinics or vans (n=8, 40%). 
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The survey also questioned participants regarding substance use services accessed and if 
they felt satisfied with the support received by these services. Table 3 describes Non-MOUD 
substance use services accessed by participants. For the non-medication-based group, these 
services were not utilized as much as healthcare services medical detox (n=34, 42%), peer-help 
groups (n=29, 35.8%), and counseling (n=28, 34.6%) were accessed the most.  
Table 3 
Non-MOUD Substance Use 
Services Accessed (N=81) 
% n 
Medical detox 42.0 34 
Peer help groups (NA, AA, 
SMART Recovery, etc.) 
35.8 29 
Counselling one on one 34.6 28 
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Figure 2  represents the satisfaction rates of those using non-MOUD services. Overall, 












Table 4 describes MOUD substance use services accessed by participants. Prescribed 
MOUD. has strong evidence in reducing illicit opioid use, mortality, drug-related HIV risk 
behaviors and crime and has been shown to be very cost-effective (Hall et al., 2021). 42 of 81 
participants accessed any kind of medication, with buprenorphine pills (n=31, 35.8%) and 
methadone (n=21, 27.2%) being the more utilized options.  
 
Table 4 MOUD Substance Use 
Services Accessed (N=81) 
% n 
Buprenorphine (pills) from a 
prescriber 
35.8 31 
Methadone from a clinic 27.2 21 
Buprenorphine (injectable) 
from a prescriber 
13.6 11 
Naltrexone (injectable) 12.3 10 
Accessed ANY Medication 51.9 42 
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Figure 3  represents the satisfaction rates of those using MOUD services. Overall, beside 
the naltrexone shots also known as Vivitrol, the satisfaction with these services is mixed 
(although there was a small sample size). We also have to consider that our SSP participants are 
engaging with an exchange potentially because these services did not lead to abstinence or 
desired control of their use. 
Figure 3 
 
The next portion of the results examines barriers SSP participants face when accessing 
medical care (Table 5). The 3 most common responses were a lack of transportation (n=27, 
33.3%), being afraid of disrespect because of their drug use (n=24, 29.6%), and someone besides 
a medical professional treated their issue or they treated themselves (n=24, 29.6%).  
 
Table 5 
Number of Participants 
(N=81) 
% n 
No transportation 33.3 27 
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Number of Participants 
(N=81) 
% n 




Someone else treated me (not 
a doctor or nurse) or I treated 
myself 
29.6 24 
Could not pay 24.7 20 
Treated poorly in the past 18.5 15 




Don’t care about taking care 
of myself at this time 
16.0 
13 
Unsure where to go 14.8 12 
Unable to get care because 
“to high or too drunk” 
14.8 
12 




Clinic hours inconvenient 11.1 9 
Didn’t have childcare 2.5 2 
 
Figure 4 shows how many barriers each participant faces. 21 of our 81 participants 
experience no barriers to healthcare. However, the majority of the participants have at least 1 
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Statistical analysis was used to see if there was an association between accessing 
healthcare services and months engaging with an SSP. Only 64 participants were used, as this 
was a fill-in answer and some of the responses were not specific enough to categorize. Access of 
non-emergent services was the focus, as it is well documented in the literature that PWID often 
utilize emergency service. To look for an association, a chi square test was performed despite this 
being a smaller sample size. There was not a relation between engagement in an SSP and 
accessing non-emergent care or primary care.  
Statistical analysis was also used to see if there was an association between accessing 
substance use services and months engaging with an SSP. Overall, MOUD is utilized less than 
others. The literature documents this could be due to barriers such as negative MOUD 
perceptions, fear of experiencing stigma, cost and a perceived lack of flexibility. The chi square 
test found that there was not a relation between engagement in an SSP and accessing non-MOUD 
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We also included how participants felt COVID has affected their access to services (Table 
7). The category least affected was naloxone, with 81.7% (n=58) stating there was no change in 
access. Syringes, healthcare services, and substance use services had similar results, with 
healthcare services having the highest percentage of participants reporting access becoming more 
difficult.                                                   
Table 7 
Since COVID-19 
how has your access 
changed to access: 
Harder to Access % No Change % Easier to Access % 
Sterile Syringes 
(n=61) 
21.3 63.9 14.8 
Healthcare Services 
(n=66) 
39.4 56.1 4.5 
Substance Use 
Services (n=67) 
32.8 58.2 9.0 




Primary care is effective for addressing many of the complex health needs of PWID, as 
they can provide screenings, vaccinations, PreP, MOUD, and can foster a long-term relationship. 
PWID engaged in primary care are more likely to initiate and maintain MOUD and abstain from 
drug use (Motavelli et al., 2021). This is consistent with our results, as these participants felt the 
most supported by primary care. However, emergency medical services are utilized more often, 
as we also saw in our data with 55 of 81 (67.9%) participants utilizing this service. In this study 
as well, the ED was utilized more, but participants were not as satisfied.  The literature 
documents that while emergency departments have developed innovative protocols to address the 
unmet needs of PWID accessing emergency services, they are not designed or resourced for 
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delivering preventive services, providing long-term management of SUD, or addressing social 
needs (Motavelli et al., 2021). 
MOUD, especially methadone and buprenorphine, has strong evidence in reducing illicit 
opioid use, mortality, drug-related HIV risk behaviors and crime and has been shown to be very 
cost-effective. The most reported barriers overall were negative perceptions, fear of experiencing 
stigma, cost, and a perceived lack of flexibility around OST (Hall et al., 2021). The participants 
in this study were also not as satisfied with these services. As previously stated, one must also 
consider that the SSP participants are engaging with an exchange potentially because these 
services did not lead to abstinence or desired control of their use.  
For barriers, 60 of 81 (74%) participants face at least one barrier to care, the most 
common barriers: Fear of judgement, lack of transportation, and self-treatment. COVID has also 
negatively impacted  this population’s access to resources (Nolte et al., 2020). Despite the lack of 
statistical relation between length of SSP engagement and access to non-emergent, primary care, 
non-MOUD and MOUD services, the sample size was small and therefore is not as reliable. The 
nature of this association and what is means for future research still needs to be further analyzed.  
SSPs are in a unique position of interacting with PWID on a regular basis. These 
programs have to power to engage more participants in health services such as primary care, 
MOUD, and other resources. These referrals to primary care can result in better long-term 
management of their complex needs and a reduction in complications.  
There are a few limitations to this study. The environment the surveys were taken in may 
have affected the results. Due to the COVID-19 pandemic data collection occurred outdoors, so 
participants may have spent less time on their answers in order to finish. Some participants also 
had to be excluded for incomplete surveys. The statistical analyses may also not be as accurate, 
HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS 16 
 
 
as only 64 participants could be included in the analysis due to some missing data. A larger 
sample size would have yielded more accurate results in the analysis portion of this study. While 
this was one of the largest groups for all the SSP sites surveyed, responses were still less than the 
preferred amount for the chi square test, as only 64 of the participants’ responses for length of 
time were able to be deciphered.  
Conclusions 
 This study effectively engaged SSP participants to assess factors that enable or constrain 
their healthcare involvement. Primary care was the most utilized non-emergent service in the 
study. PWID also felt the most supported by primary care services. It is recommended that 
PWID regularly engage with primary care for screenings, MOUD, and other long-term 
management. While the emergency department was used more frequently, emergency services 
cannot regularly provide long-term management of PWID’s complex needs. While MOUD is 
documented in the literature to reduce illicit opioid use, these medications are underutilized. 
Common barriers to healthcare include fear of judgment, lack of transportation, and self-
treatment. COVID-19 has also affected access to resources, which public health officials and 
SSPs should take into consideration for the future. In terms of association between length of SSP 
engagement and accessing services, more research is needed with a larger sample size. 




Artenie, A., Jutras-Aswad, D., Roy, E., Zang, G., Bamvita, J., Levesque, A., & Bruneau, 
J. (2015) Visits to primary care physicians among persons who inject drugs at high risk of 
hepatitis C virus infection: room for improvement. Journal of Viral Hepatology, 22 (10), 792-9. 
doi: 10.1111/jvh.12393 
 Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., 
Mimiaga, M. J., Saitz, R., & Bazzi, A. R. (2019). Strategies used by people who inject drugs to 
avoid stigma in healthcare settings. Drug and Alcohol Dependence, 198, 80–86. 
https://doi.org/10.1016/j.drugalcdep.2019.01.037 
Centers for Disease Control and Prevention (CDC). (2016). Persons Who Use Drugs: 
Strategies for Disease Prevention. Retrieved from https://www.cdc.gov/pwud/disease-
prevention.html 
Centers for Disease Control and Prevention (CDC). (2017). Reducing Harms from 
Injection Drug Use and Opioid Use Disorder with Syringe Services Programs. Retrieved from 
https://www.cdc.gov/hiv/pdf/risk/cdchiv-fs-syringe-services.pdf 
Centers for Disease Control and Prevention (CDC). (2018). Drug Overdose Deaths. 
Retrieved from https://www.cdc.gov/drugoverdose/data/statedeaths.html 
                   Davis, A. K., & Rosenberg, H. (2013). Acceptance of non-abstinence goals by addiction 
professionals in the United States. Psychology of Addictive Behaviors: Journal of the Society of 
Psychologists in Addictive Behaviors, 27(4), 1102–1109. https://doi.org/10.1037/a0030563 
                      Hall, N. Y., Le, L., Majmudar, I., & Mihalopoulos, C. (2021). Barriers to accessing 
opioid substitution treatment for opioid use disorder: A systematic review from the client 
HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS 18 
 
 
perspective. Drug and Alcohol Dependence, 221, 108651. 
https://doi.org/10.1016/j.drugalcdep.2021.108651                  
                     Hawk, M., Coulter, R. W. S., Egan, J. E., Fisk, S., Reuel Friedman, M., Tula, M., & 
Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 
14(1), 70. https://doi.org/10.1186/s12954-017-0196-4 
                     Henwood, B. F., Padgett, D. K., & Tiderington, E. (2014). Provider views of 
harm reduction versus abstinence policies within homeless services for dually diagnosed adults. 
The Journal of Behavioral Health Services & Research, 41(1). https://doi.org/10.1007/s11414-
013-9318-2Kidorf, K., King, V., Peirce, J., Kolodner, K., & Brooner RK. (2011) Benefits of 
concurrent syringe exchange and substance abuse treatment participation. Journal of Substance 
Abuse Treatment, 40(3), 265-71.  
Motavalli, D., Taylor, J. L., Childs, E., Valente, P. K., Salhaney, P., Olson, J., Biancarelli, 
D. L., Edeza, A., Earlywine, J. J., Marshall, B. D. L., Drainoni, M.-L., Mimiaga, M. J., Biello, K. 
B., & Bazzi, A. R. (2021). “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to 
Primary Care Among People Who Inject Drugs. Journal of General Internal Medicine, 36(1), 
129–137. https://doi.org/10.1007/s11606-020-06201-6Nolte, K., Drew, A.L., Friedmann, P.D., 
Romo, E., Kinney, L. E., & Stopka, T. J. (2020). Opioid initiation and injection transition in rural 
northern New England: A mixed-methods approach. Drug and Alcohol Dependence, 217 (2020). 
https://doi.org/10.1016/j.drugalcdep.2020.108256 
                  Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at Every Turn: Health 
Services Experiences among People Who Inject Drugs. The International Journal on Drug 
Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004 
HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS 19 
 
 
                 Small, W., Van Borek, N., Fairbairn, N., Wood, E., & Kerr, T. (2009). Access to health and 
social services for IDU: The impact of a medically supervised injection facility. Drug and 
Alcohol Review, 28(4), 341–346. https://doi.org/10.1111/j.1465-3362.2009.00025.x 
                Wakeman, S. E., Metlay, J. P., Chang, Y., Herman, G. E., & Rigotti, N. A. (2017). Inpatient 
Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and 
Reduces Addiction Severity. Journal of General Internal Medicine, 32(8), 909–916. 
https://doi.org/10.1007/s11606-017-4077-z 
 
 
 
